胰岛β细胞Fxr感应肠道菌群动态调控胰岛β细胞功能储备发育的作用机制研究
批准号:
92157112
项目类别:
重大研究计划
资助金额:
50.0 万元
负责人:
顾燕云
依托单位:
学科分类:
糖尿病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
顾燕云
中文摘要
胰岛β细胞功能储备不足是2型糖尿病发病的核心病理生理机制。阐明β细胞功能储备建立机制是防治2型糖尿病的关键。哺乳期内β细胞发育和mass扩容是成年后β细胞功能储备建立的关键步骤,但其调控机制尚不清楚。肠道菌群及其次级代谢物可介导环境因素影响宿主代谢器官功能,而其发育成熟也在哺乳期内完成。课题组前期实验证明:肠道菌群发育成熟过程中胆汁酸代谢能力升高;而菌群相关胆汁酸组分可通过胰岛胆汁酸信号参与调控β细胞功能储备及糖尿病治疗预后。课题组研究发现:胰岛β细胞胆汁酸受体Fxr表达适时下降是出生后β细胞促进Pdx1、MafA表达,代谢重塑及成熟功能储备建立的必要条件。课题组将利用可诱导β细胞特异过表达小鼠,在不同时间点过表达Fxr,比较小鼠胰岛β细胞功能储备变化,利用靶向代谢组学,宏基因组学及单细胞测序等技术,研究哺乳期β细胞Fxr在感应肠道菌群发育,建立胰岛β细胞功能储备中的作用及动态调控机制。
英文摘要
The irreversible loss of β cell functional preserve is the core pathogenesis of Type 2 diabetes. It has been known that weaning is the key period in individual to establish sufficient β cell functional mass in the life time, after that the β cell mass is kept in slow turnover rate and maintaining in a steady volume until drastic environmental changes occur. Though the key pancreatic transcription factors to modulate the process of β cell functional maturation during have been identified, the mechanism whereby they sense the environmental cues and how they mediate the cues to regulate β cell mass homeostasis awaits to be clarified and currently heatedly studied. Our previous work has suggested that mTORC1, the main cellular nutrient sensor, is essential for β cell functional maturation to build up sufficient β cell functional repertoires as well as compensatory capacity. However, the first sensor of nutrient intake changes in human body is gut microbiome. We have confirmed that the differences of bile acids profiles reflected the different enterotypes, i.e. the different types of gut microbiome symbiosis in the human. During weaning, the switch of food types drives the gut microbiota of infant maturing, which synchronizes with the maturation of host metabolic organ, such as endocrine pancreas. In the aid of β cell specific knock-in Fxr (bile acid receptor) mouse model, we found the timely sequestered BA signalling in pancreatic islets could be key to normal β cell maturation during weaning. We herein propose this project to study on the potential link between the gut microbiome and endocrine pancreas maturation and the underlying molecular mechanism (bacterial bile acid metabolism) of cross talk between gut microbiome and endocrine pancreas during postnatal maturation. By employing the inducible organ specific knock in mouse model, single cell RNA seq and single cell ATAC seq on primary islets,histochemistry, islet biology, metagenomics and metabolomics, we will compared the β cells with overexpression Fxr at different time points during weaning and hence study the potential molecular mechanism regulated by and key time window it works to establish sufficient β cell functional repertoire. We will identify specific BA species and microbial taxa that might target β cell and be involved in its maturation. This project will allow us to identify microbiota derived druggable targets on enhancing pancreatic beta cell preserve that could prevent and treat T2D.
胰岛β细胞功能储备不足是糖尿病发病的核心病理生理机制。从新生儿出生到断奶的过程中,肠道微生物群跟随饮食转换而发生剧烈变化,即微生物组成熟。这一阶段也是宿主内分泌胰腺/胰岛β细胞发育成熟的关键窗口期。最新研究发现,哺乳期肠道菌群成熟与多种关键脏器的发育息息相关,而与胰腺发育关系未见报道。出生后肠道微生物组成熟的一个主要特征就是BA代谢能力的增强,胰岛β细胞内最重要的胆汁酸感受器为核受体FXR,因此 我们认为生命早期FXR是否可能感应菌群胆汁酸变化从而协助胰岛β细胞mass建立和实现功能成熟。基于此假设,课题组利用无菌(GF,germ-free)小鼠模型,从出生到成年各阶段检测无菌和con(conventional raised)环境下小鼠血浆中BA各组分含量;发现随着肠道菌群的成熟,宿主次级胆汁酸和非结合胆汁酸比例逐渐升高,内源性FXR拮抗型胆汁酸TβMCA减少,FXR激动水平上调。与之呼应,出生后胰岛β细胞内FXR表达水平逐渐下降。β细胞特异性过表达FXR(βFxrKI)的小鼠出生后血糖升高,β细胞增殖能力下降同时升高其凋亡水平,β细胞转分化到其他细胞,最终降低出生后β细胞mass但糖促胰岛素分泌功能未受损。单细胞RNA测序(single-cell RNA sequencing)和单细胞ATAC测序(single-cell Assay for Transposase Accessible Chromatin with sequencing)技术,发现FXR降低β细胞内胰岛素合成和身份维持相关基因的表达,转录上调Casp6和For1,促进细胞内在凋亡和去分化。总体来说,我们研究首次建立了出生后菌群发育可能影响β细胞发育的相关机制。出生后β细胞内FXR表达水平逐渐下降,与体内菌群代谢下FXR激动型胆汁酸成分升高相适应,以避免下游caspase-6和Folr1的升高,从而保证生命早期足够的β细胞mass扩增。
肠道共生菌调控2型糖尿病胰岛β细胞功能分化重塑的机制研究
-
批准号:81870555
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:顾燕云
-
依托单位:
肠道寄生菌群通过调节胆汁酸代谢促进2型糖尿病致病的分子生物学机制研究
-
批准号:81670761
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:顾燕云
-
依托单位:
雷帕霉素不敏感mTOR伴随蛋白(Rictor)调节胰岛β细胞功能的分子机制
-
批准号:81200563
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:顾燕云
-
依托单位:
国内基金
海外基金